KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Prepaid Assets (2018 - 2025)

Vir Biotechnology's Prepaid Assets history spans 8 years, with the latest figure at $45.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 5.41% year-over-year to $45.1 million; the TTM value through Dec 2025 reached $45.1 million, down 5.41%, while the annual FY2025 figure was $45.1 million, 5.41% down from the prior year.
  • Prepaid Assets for Q4 2025 was $45.1 million at Vir Biotechnology, up from $37.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $97.6 million in Q1 2023 and bottomed at $1.0 million in Q2 2024.
  • The 5-year median for Prepaid Assets is $41.9 million (2025), against an average of $40.5 million.
  • The largest annual shift saw Prepaid Assets crashed 95.8% in 2024 before it skyrocketed 4046.9% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $73.0 million in 2021, then plummeted by 63.84% to $26.4 million in 2022, then skyrocketed by 99.05% to $52.5 million in 2023, then fell by 9.18% to $47.7 million in 2024, then fell by 5.41% to $45.1 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Prepaid Assets are $45.1 million (Q4 2025), $37.0 million (Q3 2025), and $41.5 million (Q2 2025).